Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
Condition(s):Migraine; Cannabis; THCLast Updated:March 6, 2024Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Migraine; Cannabis; THCLast Updated:March 6, 2024Enrolling by invitation
Condition(s):Migraine; Cannabis; THC; CBDLast Updated:February 28, 2023Completed
Condition(s):Repetitive Transcranial Magnetic Stimulation (rTMS); Schizophrenia; Cannabis Use Disorder; CognitionLast Updated:September 5, 2023Completed
Condition(s):CannabisLast Updated:August 2, 2018Completed
Condition(s):Alcohol Approach/Avoidance Task; Sham Approach/Avoidance TaskLast Updated:September 28, 2018Completed
Condition(s):Cannabis Use DisorderLast Updated:August 9, 2023Completed
Condition(s):Cannabis Use DisorderLast Updated:January 22, 2024Completed
Condition(s):CannabisLast Updated:August 21, 2023Suspended
Condition(s):Schizophrenia; Cannabis-Induced DisorderLast Updated:March 13, 2024Recruiting
Condition(s):Cannabis Use Disorder; PsychosisLast Updated:September 11, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.